Suppressor of Fused (Sufu) Promotes Epithelial-Mesenchymal Transition (EMT) in Cervical Squamous Cell Carcinoma

Oncotarget - United States
doi 10.18632/oncotarget.23176
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

DPY30 Regulates Cervical Squamous Cell Carcinoma by Mediating Epithelial–mesenchymal Transition (EMT)

OncoTargets and Therapy
OncologyPharmacology
2019English

DDB2 Regulates Epithelial-To-Mesenchymal Transition (EMT) in Oral/Head and Neck Squamous Cell Carcinoma

Oncotarget
Oncology
2018English

Biomarkers of Epithelial-Mesenchymal Transition in Squamous Cell Carcinoma

Journal of Dental Research
Dentistry
2012English

Loss of Trop2 Promotes Carcinogenesis and Features of Epithelial to Mesenchymal Transition in Squamous Cell Carcinoma

Molecular Cancer Research
Cancer ResearchOncologyMolecular Biology
2011English

Epigenetic Silencing of HIC1 Promotes Epithelial-Mesenchymal Transition and Drives Progression in Esophageal Squamous Cell Carcinoma

Oncotarget
Oncology
2015English

Smoothened (SMO); Suppressor of Fused Homolog (SUFU)

Science-Business eXchange
2009English

Long Non Coding RNA MALAT1 Promotes Tumor Growth and Metastasis by Inducing Epithelial-Mesenchymal Transition in Oral Squamous Cell Carcinoma

Scientific Reports
Multidisciplinary
2015English

Tumor Budding Correlates With Poor Prognosis and Epithelial-Mesenchymal Transition in Tongue Squamous Cell Carcinoma

Journal of Oral Pathology and Medicine
Cancer ResearchOral SurgeryOtorhinolaryngologyForensic MedicinePathologyPeriodontics
2011English

Uc.416 + a Promotes Epithelial-To-Mesenchymal Transition Through miR-153 in Renal Cell Carcinoma

BMC Cancer
Cancer ResearchOncologyGenetics
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy